Inventor
STEWART KENT D
US30 patents
⚠️ This page may combine multiple inventors who share the name “STEWART KENT D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
13 patentsUS6455571B1Sep 24, 2002
Inhibitors of neuraminidases
ABBOTT LAB60 citations95
US6258822B1Jul 10, 2001
Urokinase inhibitors
ABBOTT LAB70 citations95
US6284796B1Sep 4, 2001
Ukokinase inhibitors
ABBOTT LAB20 citations92
US6232456B1May 15, 2001
Serine protease reagents and methods useful for detecting and treating diseases of the prostate
ABBOTT LAB36 citations92
US7262207B2Aug 28, 2007
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
ABBOTT LAB13 citations83
US7238724B2Jul 3, 2007
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
ABBOTT LAB18 citations83
US7378414B2May 27, 2008
Anti-infective agents
ABBOTT LAB17 citations82
US6518305B1Feb 11, 2003
Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
ABBOTT LAB6 citations62
US6831096B2Dec 14, 2004
Inhibitors of neuraminidases
ABBOTT LAB3 citations61
US7538105B2May 26, 2009
Anti-infective agents
ABBOTT LAB0 citations50
US7834012B2Nov 16, 2010
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
ABBOTT LAB1 citations49
US7902203B2Mar 8, 2011
Anti-infective agents
ABBOTT LAB0 citations39
US7795248B2Sep 14, 2010
Substituted 7,8-dihydro-1H-pyrimido[4,5-B][1,4]diazepin-4-amines are novel kinase inhibitors
ABBOTT LAB0 citations38
ABBVIE INC
5 patentsUSRE47221EFeb 5, 2019
Tricyclic compounds
ABBVIE INC42 citations97
US9365579B2Jun 14, 2016
Tricyclic compounds
ABBVIE INC50 citations96
US9139536B2Sep 22, 2015
Anti-infective agents and uses thereof
ABBVIE INC2 citations62
US9095590B2Aug 4, 2015
Anti-infective agents and uses thereof
ABBVIE INC3 citations62
US9856234B2Jan 2, 2018
Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
ABBVIE INC0 citations51